2026年3月3日，广东东阳光药业股份有限公司（06887）发布截至2026年2月28日的股份变动月报表。公告显示，截至报告期末，公司注册股本为人民币576,656,047元，包含H股与内资股。其中H股法定/注册股份数为112,712,832股，内资股法定/注册股份数为463,943,215股，整体保持不变。
根据月报表，H股于本月无新增发行或回购，已发行股份（不包括库存股份）维持在112,089,032股，库存股份则保持在623,800股；内资股的已发行股份（不包括库存股份）与库存股份数目亦无变化，分别维持在463,943,215股与0股。
公告同时披露，公司并无关于员工期权、可换股票据或其他相关权证的任何新增或变动，亦无任何购回、注销行为。公司确认已遵守香港联交所《上市规则》的相关要求。公告由董事张英俊签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.